Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Cilostazol
Drug ID BADD_D00466
Description Cilostazol is a quinolinone derivative and antiplatelet agent with vasodilating properties that has been used in the symptomatic treatment of intermittent claudication in patients with peripheral ischaemia. It is marketed under the brand name Pletal by Otsuka Pharmaceutical Co.. Cilostazol works by inhibiting both primary and secondary aggregation and reducing calcium-induced contractions.
Indications and Usage Indicated for the alleviation of symptoms of intermittent claudication (pain in the legs that occurs with walking and disappears with rest).
Marketing Status approved; investigational
ATC Code B01AC23
DrugBank ID DB01166
KEGG ID D01896
MeSH ID D000077407
PubChem ID 2754
TTD Drug ID D03VPC
NDC Product Code 70518-2208; 66039-113; 50268-177; 0054-0028; 46438-0633; 0093-2065; 70436-157; 0054-0044; 63629-8795; 71610-037; 70436-156; 46438-1109; 42291-453; 50090-5329; 60505-2521; 58175-0379; 63415-0034; 60505-2522; 63629-8796; 72189-116; 46438-0632; 50268-176; 70518-2714; 42185-7038; 0093-2064
UNII N7Z035406B
Synonyms Cilostazol | 6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone | OPC 13013 | OPC-13013 | Pletal
Chemical Information
Molecular Formula C20H27N5O2
CAS Registry Number 73963-72-1
SMILES C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Abnormal faeces07.01.03.001--Not Available
Acute myocardial infarction02.02.02.001; 24.04.04.0010.000300%Not Available
Agranulocytosis01.02.03.001--Not Available
Albuminuria20.02.01.001--Not Available
Altered state of consciousness19.07.01.003; 17.02.04.0010.000300%Not Available
Amblyopia06.02.01.001--Not Available
Anaemia01.03.02.0010.000600%
Angina pectoris24.04.04.002; 02.02.02.002--
Angioedema22.04.02.008; 23.04.01.001; 10.01.05.0090.000660%Not Available
Anxiety19.06.02.002--
Aphasia17.02.03.001; 19.21.01.0010.000300%
Aplastic anaemia01.03.03.002--Not Available
Arteriovenous fistula24.03.03.0010.000300%Not Available
Arthralgia15.01.02.001--
Arthritis15.01.01.001--
Asthenia08.01.01.001--Not Available
Asthma22.03.01.002; 10.01.03.010--Not Available
Atrial fibrillation02.03.03.0020.000960%
Atrial flutter02.03.03.003--
Atrioventricular block complete02.03.01.003--
Back pain15.03.04.005--
Bladder pain20.02.02.001--Not Available
Blindness06.02.10.003; 17.17.01.003--Not Available
Blood creatinine increased13.13.01.004--
Blood glucose increased13.02.02.002--Not Available
Blood pressure increased13.14.03.005--Not Available
Blood urea increased13.13.01.006--Not Available
Blood uric acid increased13.02.04.001--Not Available
Body temperature increased13.15.01.001--Not Available
The 1th Page    1 2 3 4 5    Next   Last    Total 8 Pages